Epigenomics adjusts conversion price on outstanding mandatory convertible bond after EUR 219,244 capital increase

Epigenomics reset the conversion price on its mandatory convertible bond 2021/2027 following a registered cash capital increase. Adjusted conversion ratio set at 1 (nominal EUR 100): 4.7438 shares, effective Oct. 15, 2026. Company issued 219,244 new registered shares at an issue price of EUR 1.00 per share. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Epigenomics AG published the original content used to generate this news brief via pressetext (Ref. ID: 202610140730PRESSTXTEUPR__DEFAE18E7FF7C125D08FF8089EFF10CBC) on October 14, 2026, and is solely responsible for the information contained therein. (C)